Stapokibart provides significant improvements in signs and symptoms of atopic dermatitis irrespective of prior systemic treatment: a post-hoc analysis of a phase 3 trial.

Zhao Y, Zhang L, Wu L, Yang B, Wang J, Li Y, Diao Q, Li J, Sun Q, Zhu X, Man X, Wang L, Feng Y, Cai T, Zeng H, Li L, Lu J, Ren H, Li F, Lu Q, Tao X, Xiao R, Ji C, Zhao W, Chu W, Chen B, Zhang J

Open source

DOI: 10.1080/09546634.2026.2670890
Published: 2026 Dec
Container: The Journal of dermatological treatment
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/09546634.2026.2670890,
  title = {Stapokibart provides significant improvements in signs and symptoms of atopic dermatitis irrespective of prior systemic treatment: a post-hoc analysis of a phase 3 trial.},
  author = {Zhao Y and Zhang L and Wu L and Yang B and Wang J and Li Y and Diao Q and Li J and Sun Q and Zhu X and Man X and Wang L and Feng Y and Cai T and Zeng H and Li L and Lu J and Ren H and Li F and Lu Q and Tao X and Xiao R and Ji C and Zhao W and Chu W and Chen B and Zhang J},
  year = {2026},
  journal = {The Journal of dermatological treatment},
  doi = {10.1080/09546634.2026.2670890},
  url = {https://doi.org/10.1080/09546634.2026.2670890}
}

RIS

TY  - JOUR
TI  - Stapokibart provides significant improvements in signs and symptoms of atopic dermatitis irrespective of prior systemic treatment: a post-hoc analysis of a phase 3 trial.
AU  - Zhao Y
AU  - Zhang L
AU  - Wu L
AU  - Yang B
AU  - Wang J
AU  - Li Y
AU  - Diao Q
AU  - Li J
AU  - Sun Q
AU  - Zhu X
AU  - Man X
AU  - Wang L
AU  - Feng Y
AU  - Cai T
AU  - Zeng H
AU  - Li L
AU  - Lu J
AU  - Ren H
AU  - Li F
AU  - Lu Q
AU  - Tao X
AU  - Xiao R
AU  - Ji C
AU  - Zhao W
AU  - Chu W
AU  - Chen B
AU  - Zhang J
PY  - 2026
JO  - The Journal of dermatological treatment
DO  - 10.1080/09546634.2026.2670890
UR  - https://doi.org/10.1080/09546634.2026.2670890
ER  -

APA

Y, Z., L, Z., L, W., B, Y., J, W., Y, L., Q, D., J, L., Q, S., X, Z., X, M., L, W., Y, F., T, C., H, Z., L, L., J, L., H, R., F, L., Q, L., X, T., R, X., C, J., W, Z., W, C., B, C., & J, Z. (2026). Stapokibart provides significant improvements in signs and symptoms of atopic dermatitis irrespective of prior systemic treatment: a post-hoc analysis of a phase 3 trial.. The Journal of dermatological treatment. https://doi.org/10.1080/09546634.2026.2670890

Source records

pubmed · retrieved 2026-09-27T15:12:34.233Z